TCPL Packaging: Evaluating Investment Prospects

Despite a sombre financial performance in FY24, TCPL’s stock gained 43 per cent during the financial year. The valuation expanded to a PE of 19.55 and a PBV of 3.72. Normally, a stock’s price is expected to underperform during periods of declining operating profitability, unless the stock is undervalued. In other words, it is reasonable (and justified) for a stock to deliver superior returns even during periods of declining profitability if the stock was undervalued in the first place.

The Reckoning

The purpose of the financial system is to support the ‘real’ economy by facilitating transactions, majorly through credit and money supply. But on certain occasions, the financial system would dissociate from its principal purpose and start functioning for its own sake – its expansion and survival. Unfortunately, the financial system gets seized by many ill effects if dissociated from its primary purpose. Precariously high asset prices, credit booms, capital misallocation, and financial fraud are a few of the ill effects.

Buy into Uncertainty

This edition of our analysis, dated 19 June 2024, discusses the investment prospects of these stocks: Dynemic Products, RACL Geartech, and Kovai Medical Center.

Intellectual Malleability

"Investors must embrace intellectual malleability to navigate the changing investment landscape. Holding onto outdated beliefs can hinder success. Recognizing and adjusting counterproductive behaviours is essential for productive investing."

Choosing the Right Stock for Your Portfolio

Investing based on recent stock performance is ineffective. Instead, focus on a stock's expected profitability and earnings power. This method may increase your odds of achieving superior returns. Read on to Know More...

Stock Review: Dynemic Products

The stock market can be a rollercoaster ride, with many ups and downs. Dynemic Products is no exception, with its stock experiencing significant price drops in recent years. In this stock review, we'll explore the investment prospects of Dynemic Products and discuss whether it's worth investing in this company. So, let's dive in and see what opportunities and challenges lie ahead for investors.

Calm Before the Storm

The outlook discusses the current market conditions, including the rise in gold prices, the US 10-year treasury yield, and India's volatility index. The author expresses concern about the recent spike in gold prices and its potential implications for the financial markets soon.

Revisiting Natural Capsules: Is It Worth the Risk Now?

The current state of Natural Capsules' stock, its core fundamentals, and its valuation; insights for potential investors to make an informed decision. Briefing Since peaking at ₹638.95 per share on 9 Sep. 2022, the stock of Natural Capsules has been in a long decline during which it lost 50 per cent in value over one-and-half … Continue reading Revisiting Natural Capsules: Is It Worth the Risk Now? →

How to Beat the Market

Identify High-Risk Stocks That Are More Likely to Get Re-Rated, and for that, Focus on Core Fundamentals. “In the short run, the market is a voting machine. In the long run, it is a weighing machine.” Benjamin Graham “Beating the Market”: earning an investment return greater than the return of benchmark indices such as Sensex, … Continue reading How to Beat the Market →

Is Ador Fontech Stock a Buy or Sell?

Analysing ADFL's Financials and Valuation to Determine its Investment Prospects The stock of Ador Fontech trades at ₹140 per share – 11 per cent off its all-time high of ₹157.20 per share attained on 5 Jan. 2024. The stock has delivered superior returns over the past five years – 21.16 per cent annually. On a … Continue reading Is Ador Fontech Stock a Buy or Sell? →